The global market for Recombinant Collagen Liquid Dressing was valued at US$ 95.0 million in the year 2024 and is projected to reach a revised size of US$ 211 million by 2031, growing at a CAGR of 12.1% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Recombinant Collagen Liquid Dressing competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Recombinant collagen liquid dressing is a high-end medical dressing that uses humanized collagen (usually type III) synthesized using genetic engineering technology and is used in liquid form to promote skin wound repair. Its core ingredients are obtained through a recombinant expression system (such as Escherichia coli, yeast or mammalian cells), and are highly biocompatible and safe. They can significantly simulate the natural collagen structure of the human body and avoid the immune response and disease transmission risks caused by animal-derived collagen. This type of dressing is usually a transparent or light yellow fluid that can be directly sprayed or dripped on the surface of the wound, quickly forming a film, providing an excellent scaffold environment for cells, promoting fibroblast proliferation and angiogenesis, and accelerating epithelial regeneration and tissue repair.
North American market for Recombinant Collagen Liquid Dressing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Recombinant Collagen Liquid Dressing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Recombinant Collagen Liquid Dressing include CollPlant, Integra LifeSciences, Aroa Biosurgery, Botiss Biomaterials, Angelini Pharma, Sanara MedTech, Covalon Technologies, Hantai Pharmaceutical Group, Benmei Biotechnology, Ruikang Medical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Recombinant Collagen Liquid Dressing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Collagen Liquid Dressing.
The Recombinant Collagen Liquid Dressing market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Collagen Liquid Dressing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Collagen Liquid Dressing manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
CollPlant
Integra LifeSciences
Aroa Biosurgery
Botiss Biomaterials
Angelini Pharma
Sanara MedTech
Covalon Technologies
Hantai Pharmaceutical Group
Benmei Biotechnology
Ruikang Medical
Trauer Biotech
Meicui Biotechnology
Tianzheng Biotechnology
Giant Biogene
Jingzhun Medical Device Technology
Bloomage Biotech
Segment by Type
Human Origin
Animal Origin
Plant Origin
Segment by Application
Hospital
Pharmacy
Clinic
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Recombinant Collagen Liquid Dressing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Recombinant Collagen Liquid Dressing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Recombinant Collagen Liquid Dressing 麻豆原创 Overview
1.1 Product Definition
1.2 Recombinant Collagen Liquid Dressing by Type
1.2.1 Global Recombinant Collagen Liquid Dressing 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 Human Origin
1.2.3 Animal Origin
1.2.4 Plant Origin
1.3 Recombinant Collagen Liquid Dressing by Application
1.3.1 Global Recombinant Collagen Liquid Dressing 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Clinic
1.3.5 Others
1.4 Global Recombinant Collagen Liquid Dressing 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Recombinant Collagen Liquid Dressing Revenue 2020-2031
1.4.2 Global Recombinant Collagen Liquid Dressing Sales 2020-2031
1.4.3 Global Recombinant Collagen Liquid Dressing 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Recombinant Collagen Liquid Dressing 麻豆原创 Competition by Manufacturers
2.1 Global Recombinant Collagen Liquid Dressing Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Recombinant Collagen Liquid Dressing Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Recombinant Collagen Liquid Dressing Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Recombinant Collagen Liquid Dressing, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Collagen Liquid Dressing, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Collagen Liquid Dressing, Product Type & Application
2.7 Global Key Manufacturers of Recombinant Collagen Liquid Dressing, Date of Enter into This Industry
2.8 Global Recombinant Collagen Liquid Dressing 麻豆原创 Competitive Situation and Trends
2.8.1 Global Recombinant Collagen Liquid Dressing 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Recombinant Collagen Liquid Dressing Players 麻豆原创 Share by Revenue
2.8.3 Global Recombinant Collagen Liquid Dressing Company Type and 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Collagen Liquid Dressing 麻豆原创 Scenario by Region
3.1 Global Recombinant Collagen Liquid Dressing 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Recombinant Collagen Liquid Dressing Sales by Region: 2020-2031
3.2.1 Global Recombinant Collagen Liquid Dressing Sales by Region: 2020-2025
3.2.2 Global Recombinant Collagen Liquid Dressing Sales by Region: 2026-2031
3.3 Global Recombinant Collagen Liquid Dressing Revenue by Region: 2020-2031
3.3.1 Global Recombinant Collagen Liquid Dressing Revenue by Region: 2020-2025
3.3.2 Global Recombinant Collagen Liquid Dressing Revenue by Region: 2026-2031
3.4 North America Recombinant Collagen Liquid Dressing 麻豆原创 Facts & Figures by Country
3.4.1 North America Recombinant Collagen Liquid Dressing 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Recombinant Collagen Liquid Dressing Sales by Country (2020-2031)
3.4.3 North America Recombinant Collagen Liquid Dressing Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Collagen Liquid Dressing 麻豆原创 Facts & Figures by Country
3.5.1 Europe Recombinant Collagen Liquid Dressing 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Recombinant Collagen Liquid Dressing Sales by Country (2020-2031)
3.5.3 Europe Recombinant Collagen Liquid Dressing Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Collagen Liquid Dressing 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Collagen Liquid Dressing 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Recombinant Collagen Liquid Dressing Sales by Region (2020-2031)
3.6.3 Asia Pacific Recombinant Collagen Liquid Dressing Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Recombinant Collagen Liquid Dressing 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Recombinant Collagen Liquid Dressing 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Recombinant Collagen Liquid Dressing Sales by Country (2020-2031)
3.7.3 Latin America Recombinant Collagen Liquid Dressing Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Recombinant Collagen Liquid Dressing 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Collagen Liquid Dressing 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Recombinant Collagen Liquid Dressing Sales by Country (2020-2031)
3.8.3 Middle East and Africa Recombinant Collagen Liquid Dressing Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Collagen Liquid Dressing Sales by Type (2020-2031)
4.1.1 Global Recombinant Collagen Liquid Dressing Sales by Type (2020-2025)
4.1.2 Global Recombinant Collagen Liquid Dressing Sales by Type (2026-2031)
4.1.3 Global Recombinant Collagen Liquid Dressing Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Recombinant Collagen Liquid Dressing Revenue by Type (2020-2031)
4.2.1 Global Recombinant Collagen Liquid Dressing Revenue by Type (2020-2025)
4.2.2 Global Recombinant Collagen Liquid Dressing Revenue by Type (2026-2031)
4.2.3 Global Recombinant Collagen Liquid Dressing Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Recombinant Collagen Liquid Dressing Price by Type (2020-2031)
5 Segment by Application
5.1 Global Recombinant Collagen Liquid Dressing Sales by Application (2020-2031)
5.1.1 Global Recombinant Collagen Liquid Dressing Sales by Application (2020-2025)
5.1.2 Global Recombinant Collagen Liquid Dressing Sales by Application (2026-2031)
5.1.3 Global Recombinant Collagen Liquid Dressing Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Recombinant Collagen Liquid Dressing Revenue by Application (2020-2031)
5.2.1 Global Recombinant Collagen Liquid Dressing Revenue by Application (2020-2025)
5.2.2 Global Recombinant Collagen Liquid Dressing Revenue by Application (2026-2031)
5.2.3 Global Recombinant Collagen Liquid Dressing Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Recombinant Collagen Liquid Dressing Price by Application (2020-2031)
6 Key Companies Profiled
6.1 CollPlant
6.1.1 CollPlant Company Information
6.1.2 CollPlant Description and Business Overview
6.1.3 CollPlant Recombinant Collagen Liquid Dressing Sales, Revenue and Gross Margin (2020-2025)
6.1.4 CollPlant Recombinant Collagen Liquid Dressing Product Portfolio
6.1.5 CollPlant Recent Developments/Updates
6.2 Integra LifeSciences
6.2.1 Integra LifeSciences Company Information
6.2.2 Integra LifeSciences Description and Business Overview
6.2.3 Integra LifeSciences Recombinant Collagen Liquid Dressing Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Integra LifeSciences Recombinant Collagen Liquid Dressing Product Portfolio
6.2.5 Integra LifeSciences Recent Developments/Updates
6.3 Aroa Biosurgery
6.3.1 Aroa Biosurgery Company Information
6.3.2 Aroa Biosurgery Description and Business Overview
6.3.3 Aroa Biosurgery Recombinant Collagen Liquid Dressing Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Aroa Biosurgery Recombinant Collagen Liquid Dressing Product Portfolio
6.3.5 Aroa Biosurgery Recent Developments/Updates
6.4 Botiss Biomaterials
6.4.1 Botiss Biomaterials Company Information
6.4.2 Botiss Biomaterials Description and Business Overview
6.4.3 Botiss Biomaterials Recombinant Collagen Liquid Dressing Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Botiss Biomaterials Recombinant Collagen Liquid Dressing Product Portfolio
6.4.5 Botiss Biomaterials Recent Developments/Updates
6.5 Angelini Pharma
6.5.1 Angelini Pharma Company Information
6.5.2 Angelini Pharma Description and Business Overview
6.5.3 Angelini Pharma Recombinant Collagen Liquid Dressing Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Angelini Pharma Recombinant Collagen Liquid Dressing Product Portfolio
6.5.5 Angelini Pharma Recent Developments/Updates
6.6 Sanara MedTech
6.6.1 Sanara MedTech Company Information
6.6.2 Sanara MedTech Description and Business Overview
6.6.3 Sanara MedTech Recombinant Collagen Liquid Dressing Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sanara MedTech Recombinant Collagen Liquid Dressing Product Portfolio
6.6.5 Sanara MedTech Recent Developments/Updates
6.7 Covalon Technologies
6.7.1 Covalon Technologies Company Information
6.7.2 Covalon Technologies Description and Business Overview
6.7.3 Covalon Technologies Recombinant Collagen Liquid Dressing Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Covalon Technologies Recombinant Collagen Liquid Dressing Product Portfolio
6.7.5 Covalon Technologies Recent Developments/Updates
6.8 Hantai Pharmaceutical Group
6.8.1 Hantai Pharmaceutical Group Company Information
6.8.2 Hantai Pharmaceutical Group Description and Business Overview
6.8.3 Hantai Pharmaceutical Group Recombinant Collagen Liquid Dressing Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hantai Pharmaceutical Group Recombinant Collagen Liquid Dressing Product Portfolio
6.8.5 Hantai Pharmaceutical Group Recent Developments/Updates
6.9 Benmei Biotechnology
6.9.1 Benmei Biotechnology Company Information
6.9.2 Benmei Biotechnology Description and Business Overview
6.9.3 Benmei Biotechnology Recombinant Collagen Liquid Dressing Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Benmei Biotechnology Recombinant Collagen Liquid Dressing Product Portfolio
6.9.5 Benmei Biotechnology Recent Developments/Updates
6.10 Ruikang Medical
6.10.1 Ruikang Medical Company Information
6.10.2 Ruikang Medical Description and Business Overview
6.10.3 Ruikang Medical Recombinant Collagen Liquid Dressing Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Ruikang Medical Recombinant Collagen Liquid Dressing Product Portfolio
6.10.5 Ruikang Medical Recent Developments/Updates
6.11 Trauer Biotech
6.11.1 Trauer Biotech Company Information
6.11.2 Trauer Biotech Description and Business Overview
6.11.3 Trauer Biotech Recombinant Collagen Liquid Dressing Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Trauer Biotech Recombinant Collagen Liquid Dressing Product Portfolio
6.11.5 Trauer Biotech Recent Developments/Updates
6.12 Meicui Biotechnology
6.12.1 Meicui Biotechnology Company Information
6.12.2 Meicui Biotechnology Description and Business Overview
6.12.3 Meicui Biotechnology Recombinant Collagen Liquid Dressing Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Meicui Biotechnology Recombinant Collagen Liquid Dressing Product Portfolio
6.12.5 Meicui Biotechnology Recent Developments/Updates
6.13 Tianzheng Biotechnology
6.13.1 Tianzheng Biotechnology Company Information
6.13.2 Tianzheng Biotechnology Description and Business Overview
6.13.3 Tianzheng Biotechnology Recombinant Collagen Liquid Dressing Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Tianzheng Biotechnology Recombinant Collagen Liquid Dressing Product Portfolio
6.13.5 Tianzheng Biotechnology Recent Developments/Updates
6.14 Giant Biogene
6.14.1 Giant Biogene Company Information
6.14.2 Giant Biogene Description and Business Overview
6.14.3 Giant Biogene Recombinant Collagen Liquid Dressing Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Giant Biogene Recombinant Collagen Liquid Dressing Product Portfolio
6.14.5 Giant Biogene Recent Developments/Updates
6.15 Jingzhun Medical Device Technology
6.15.1 Jingzhun Medical Device Technology Company Information
6.15.2 Jingzhun Medical Device Technology Description and Business Overview
6.15.3 Jingzhun Medical Device Technology Recombinant Collagen Liquid Dressing Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Jingzhun Medical Device Technology Recombinant Collagen Liquid Dressing Product Portfolio
6.15.5 Jingzhun Medical Device Technology Recent Developments/Updates
6.16 Bloomage Biotech
6.16.1 Bloomage Biotech Company Information
6.16.2 Bloomage Biotech Description and Business Overview
6.16.3 Bloomage Biotech Recombinant Collagen Liquid Dressing Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Bloomage Biotech Recombinant Collagen Liquid Dressing Product Portfolio
6.16.5 Bloomage Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Collagen Liquid Dressing Industry Chain Analysis
7.2 Recombinant Collagen Liquid Dressing Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Collagen Liquid Dressing Production Mode & Process Analysis
7.4 Recombinant Collagen Liquid Dressing Sales and 麻豆原创ing
7.4.1 Recombinant Collagen Liquid Dressing Sales Channels
7.4.2 Recombinant Collagen Liquid Dressing Distributors
7.5 Recombinant Collagen Liquid Dressing Customer Analysis
8 Recombinant Collagen Liquid Dressing 麻豆原创 Dynamics
8.1 Recombinant Collagen Liquid Dressing Industry Trends
8.2 Recombinant Collagen Liquid Dressing 麻豆原创 Drivers
8.3 Recombinant Collagen Liquid Dressing 麻豆原创 Challenges
8.4 Recombinant Collagen Liquid Dressing 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
CollPlant
Integra LifeSciences
Aroa Biosurgery
Botiss Biomaterials
Angelini Pharma
Sanara MedTech
Covalon Technologies
Hantai Pharmaceutical Group
Benmei Biotechnology
Ruikang Medical
Trauer Biotech
Meicui Biotechnology
Tianzheng Biotechnology
Giant Biogene
Jingzhun Medical Device Technology
Bloomage Biotech
听
听
*If Applicable.